quinta-feira, 8 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 9, 2026

Tech stocks today: Anthropic sues Defense Department over ban, OpenAI's robotics leader resigns

View original at finance.yahoo.com
Tech stocks today: Anthropic sues Defense Department over ban, OpenAI's robotics leader resigns Anthropic (ANTH.PVT) sued the Department of Defense on Monday to block a ban on the company after the Pentagon labeled it a national security risk…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • MacBook Neo is one of the most important announcements for Apple in the Mac product line and represents a shift in the history of the Mac

    80% confidence

  • Amodei resumed negotiations with the Defense Department to put a military contract back on the table

    80% confidence

  • It's not a zero-sum game between CPUs and GPUs, because there's more and more workloads

    80% confidence

  • Autonomous vehicles and robotaxis will be the most significant change agent in the Auto 2.0 landscape

    80% confidence

  • Broadcom achieved record first quarter revenue on continued strength in AI semiconductor solutions

    80% confidence

  • OpenAI is going to go public

    80% confidence

  • AI revenue growth is accelerating and Q2 segment revenue is anticipated at $10.7 billion

    80% confidence

  • Tesla is the current leader in consumer autonomy and expected to quickly become a leader in robotaxi services

    80% confidence

  • While small amounts of H200 products for China-based customers were approved by the US government, we have yet to generate any revenue, and we do not know whether any imports will be allowed into China

    80% confidence

  • Nvidia's $10 billion investment in Anthropic will probably be the last

    80% confidence

  • Anthropic has no choice but to challenge the national security ban in court

    80% confidence

  • The promise of prediction markets is to harness the wisdom of the crowd to create accurate, unbiased forecasts for the most important events to society

    80% confidence

  • Nvidia will invest $30 billion in OpenAI and this will likely be the last investment for the foreseeable future

    80% confidence

  • Q1 AI revenue of $8.4 billion grew 106% year over year, driven by robust demand for custom AI accelerators and AI networking

    80% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Tech stocks today: Anthropic sues Defense Department over ban, OpenAI's robotics leader resigns — Source | Via News | pt.VIA.NEWS